Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

The impact of prior antithrombotic status on cerebral infarction in patients with atrial fibrillation.

Kim BJ, Kim HJ, Do Y, Lee JH, Park KY, Cha JK, Kim HY, Kwon JH, Lee KB, Kim DE, Ha SW, Sohn SI, Kwon SU.

J Stroke Cerebrovasc Dis. 2014 Sep;23(8):2054-9. doi: 10.1016/j.jstrokecerebrovasdis.2014.03.011. Epub 2014 Aug 10.

PMID:
25113085
2.

Relation of effective anticoagulation in patients with atrial fibrillation to stroke severity and survival (from the National Acute Stroke Israeli Survey [NASIS]).

Schwammenthal Y, Bornstein N, Schwammenthal E, Schwartz R, Goldbourt U, Tsabari R, Koton S, Grossman E, Tanne D.

Am J Cardiol. 2010 Feb 1;105(3):411-6. doi: 10.1016/j.amjcard.2009.09.050. Epub 2009 Dec 22.

PMID:
20102959
3.

Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.

Lamberts M, Gislason GH, Olesen JB, Kristensen SL, Schjerning Olsen AM, Mikkelsen A, Christensen CB, Lip GY, Køber L, Torp-Pedersen C, Hansen ML.

J Am Coll Cardiol. 2013 Sep 10;62(11):981-9. doi: 10.1016/j.jacc.2013.05.029. Epub 2013 Jun 7.

4.

'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.

Lip GY, Laroche C, Dan GA, Santini M, Kalarus Z, Rasmussen LH, Ioachim PM, Tica O, Boriani G, Cimaglia P, Diemberger I, Hellum CF, Mortensen B, Maggioni AP.

Am J Med. 2014 Jun;127(6):519-29.e1. doi: 10.1016/j.amjmed.2013.12.022. Epub 2014 Jan 28.

PMID:
24486284
5.

Anticoagulant and antiplatelet therapy for stroke prevention in atrial fibrillation patients in the clinical practice of a single district hospital in Poland.

Bednarski J, Cieszewska E, Strzelecki A, Filipiak KJ.

Kardiol Pol. 2013;71(12):1260-5. doi: 10.5603/KP.a2013.0179. Epub 2013 Aug 30.

6.

Cardioembolic vs. noncardioembolic strokes in atrial fibrillation: frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies.

Hart RG, Pearce LA, Miller VT, Anderson DC, Rothrock JF, Albers GW, Nasco E.

Cerebrovasc Dis. 2000 Jan-Feb;10(1):39-43.

PMID:
10629345
7.

Anticoagulant and antiplatelet therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention.

Goto K, Nakai K, Shizuta S, Morimoto T, Shiomi H, Natsuaki M, Yahata M, Ota C, Ono K, Makiyama T, Nakagawa Y, Furukawa Y, Kadota K, Takatsu Y, Tamura T, Takizawa A, Inada T, Doi O, Nohara R, Matsuda M, Takeda T, Kato M, Shirotani M, Eizawa H, Ishii K, Lee JD, Takahashi M, Horie M, Takahashi M, Miki S, Aoyama T, Suwa S, Hamasaki S, Ogawa H, Mitsudo K, Nobuyoshi M, Kita T, Kimura T; CREDO-Kyoto Registry Cohort-2 Investigators..

Am J Cardiol. 2014 Jul 1;114(1):70-8. doi: 10.1016/j.amjcard.2014.03.060. Epub 2014 Apr 24.

8.

Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy.

Hohnloser SH, Pajitnev D, Pogue J, Healey JS, Pfeffer MA, Yusuf S, Connolly SJ; ACTIVE W Investigators..

J Am Coll Cardiol. 2007 Nov 27;50(22):2156-61. Epub 2007 Nov 13.

9.

Long-term safety and efficacy of dual therapy with oral anticoagulation and clopidogrel in patients with atrial fibrillation treated with drug-eluting stents.

Seivani Y, Abdel-Wahab M, Geist V, Richardt G, Sulimov DS, El-Mawardy M, Toelg R, Akin I.

Clin Res Cardiol. 2013 Nov;102(11):799-806. doi: 10.1007/s00392-013-0592-z. Epub 2013 Jun 16.

PMID:
23771774
10.

Recurrent vascular events in patients with ischemic stroke/TIA and atrial fibrillation in relation to secondary prevention at hospital discharge.

Tentschert S, Parigger S, Dorda V, Bittner K, Unterbuchschachner D, Greisenegger S, Wimmer R, Brücke T, Lang W, Lalouschek W; Vienna Stroke Study Group..

Wien Klin Wochenschr. 2004 Dec 30;116(24):834-8.

PMID:
15690967
11.

Cognitive impairment is not a predictor of failure to adhere to anticoagulation of stroke patients with atrial fibrillation.

Horstmann S, Rizos T, Saribas M, Efthymiou E, Rauch G, Veltkamp R.

Cerebrovasc Dis. 2015;39(5-6):325-31. doi: 10.1159/000381728. Epub 2015 May 7.

12.
13.

[Modification of clinical profile of stroke in atrial fibrillation patients. Effect of antithrombotic treatment].

García Escrivà A, López Hernández N, Hernández Lorido R, Oliver Navarrete C, Bustos S, Carneado Ruiz J, Gracia Fleta F, Moltó Jordá JM.

Rev Neurol. 2004 Mar 1-15;38(5):401-5. Spanish.

14.
15.

Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.

Cullen MW, Kim S, Piccini JP Sr, Ansell JE, Fonarow GC, Hylek EM, Singer DE, Mahaffey KW, Kowey PR, Thomas L, Go AS, Lopes RD, Chang P, Peterson ED, Gersh BJ; ORBIT-AF Investigators..

Circ Cardiovasc Qual Outcomes. 2013 Jul;6(4):461-9. doi: 10.1161/CIRCOUTCOMES.113.000127. Epub 2013 Jun 11.

16.

Antithrombotic therapy after acute ischemic stroke in patients with atrial fibrillation.

McGrath ER, Kapral MK, Fang J, Eikelboom JW, Conghaile Aó, Canavan M, O'Donnell MJ; Investigators of the Ontario Stroke Registry..

Stroke. 2014 Dec;45(12):3637-42. doi: 10.1161/STROKEAHA.114.006929. Epub 2014 Nov 6. Erratum in: Stroke. 2016 Jan;47(1):e20. Conghaile, Aengus O [corrected to Conghaile, Aengus ó].

17.

Impact of atrial fibrillation and inadequate antithrombotic management on mortality in acute neurovascular syndrome.

Saarinen JT, Rusanen H, Sillanpää N, Huhtala H, Numminen H, Elovaara I.

J Stroke Cerebrovasc Dis. 2014 Oct;23(9):2256-64. doi: 10.1016/j.jstrokecerebrovasdis.2014.04.017. Epub 2014 Aug 23.

PMID:
25156784
18.

Anticoagulant and/or antiplatelet treatment in patients with atrial fibrillation after percutaneous coronary intervention. A single-center experience.

Maegdefessel L, Schlitt A, Faerber J, Bond SP, Messow CM, Buerke M, Raaz U, Werdan K, Muenzel T, Weiss C.

Med Klin (Munich). 2008 Sep 15;103(9):628-32. doi: 10.1007/s00063-008-1101-4. Epub 2008 Sep 24.

PMID:
18813885
19.

Reasons underlying non-adherence to and discontinuation of anticoagulation in secondary stroke prevention among patients with atrial fibrillation.

Gumbinger C, Holstein T, Stock C, Rizos T, Horstmann S, Veltkamp R.

Eur Neurol. 2015;73(3-4):184-91. doi: 10.1159/000371574. Epub 2015 Jan 24.

PMID:
25633474
20.

Efficacy and safety of aspirin, clopidogrel, and warfarin after coronary artery stenting in Korean patients with atrial fibrillation.

Suh SY, Kang WC, Oh PC, Choi H, Moon CI, Lee K, Han SH, Ahn T, Choi IS, Shin EK.

Heart Vessels. 2014 Sep;29(5):578-83. doi: 10.1007/s00380-013-0399-x. Epub 2013 Aug 24.

PMID:
23974943

Supplemental Content

Support Center